206 related articles for article (PubMed ID: 19908318)
41. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
[TBL] [Abstract][Full Text] [Related]
42. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
[TBL] [Abstract][Full Text] [Related]
43. [Genetic abnormalities in core binding factor acute myeloid leukemia].
Ishikawa Y
Rinsho Ketsueki; 2017; 58(8):991-998. PubMed ID: 28883285
[TBL] [Abstract][Full Text] [Related]
44. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
[TBL] [Abstract][Full Text] [Related]
45. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
Panigrahi C; Tikare N; Das PK; Padhi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
[TBL] [Abstract][Full Text] [Related]
46. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
Farra C; Awwad J; Valent A; Lozach F; Bernheim A
Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
[TBL] [Abstract][Full Text] [Related]
47. Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML.
Rücker FG; Bullinger L; Gribov A; Sill M; Schlenk RF; Lichter P; Döhner H; Döhner K
Genes Chromosomes Cancer; 2011 Jan; 50(1):51-8. PubMed ID: 20967878
[TBL] [Abstract][Full Text] [Related]
48. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival.
Schnittger S; Kohl TM; Haferlach T; Kern W; Hiddemann W; Spiekermann K; Schoch C
Blood; 2006 Mar; 107(5):1791-9. PubMed ID: 16254134
[TBL] [Abstract][Full Text] [Related]
49. Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia.
Sood R; Hansen NF; Donovan FX; Carrington B; Bucci D; Maskeri B; Young A; Trivedi NS; Kohlschmidt J; Stone RM; Caligiuri MA; Chandrasekharappa SC; Marcucci G; Mullikin JC; Bloomfield CD; Liu P
Leukemia; 2016 Feb; 30(2):501-4. PubMed ID: 26139325
[No Abstract] [Full Text] [Related]
50. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
[TBL] [Abstract][Full Text] [Related]
51. Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
Lin P; Chen L; Luthra R; Konoplev SN; Wang X; Medeiros LJ
Mod Pathol; 2008 Aug; 21(8):1029-36. PubMed ID: 18536654
[TBL] [Abstract][Full Text] [Related]
52. Translocation(8;20;21)(q22;q13;q22) in acute myeloblastic leukemia with maturation: a variant form of t(8;21).
Wong KF; Kwong YL; So CC
Cancer Genet Cytogenet; 1998 Feb; 101(1):39-41. PubMed ID: 9460498
[TBL] [Abstract][Full Text] [Related]
53. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
[TBL] [Abstract][Full Text] [Related]
54. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
55. [Molecular pathogenesis and treatment of core binding factor-acute myeloid leukemia].
Ishikawa Y
Rinsho Ketsueki; 2018; 59(10):1997-2006. PubMed ID: 30305502
[TBL] [Abstract][Full Text] [Related]
56. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract][Full Text] [Related]
57. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
[TBL] [Abstract][Full Text] [Related]
58. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
Mohamed M; Dun K
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
[TBL] [Abstract][Full Text] [Related]
59. Duplication 15q in a patient with t(8;21) acute myeloblastic leukemia (M2).
Zhang L; Mulvihill JJ; Kinasewitz GT; Scott KV; Bates F; Li S
Cancer Genet Cytogenet; 2002 Mar; 133(2):148-51. PubMed ID: 11943342
[TBL] [Abstract][Full Text] [Related]
60. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
